《Cancer Research And Treatment》是一本由KOREAN CANCER ASSOCIATION出版商出版的专业医学期刊，该刊创刊于2001年，刊期4 issues/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：肿瘤学 3区；在JCR（Journal Citation Reports）分区等级为Q2。该刊发文范围涵盖肿瘤学等领域，旨在及时、准确、全面地报道国内外肿瘤学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为5.036，平均审稿速度>12周，或约稿。

Cancer Research And Treatment英文介绍

Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association. It is published quarterly, one volume per year. Abbreviated title is Cancer Res Treat. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.

Cancer Research And Treatment中科院分区

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	2区	ONCOLOGY 肿瘤学	3区	否	否

Cancer Research And Treatment期刊近9年JCR分区变化趋势

Cancer Research And TreatmentJCR分区(JCR2021-2022年分区)

JCR分区等级	JCR所属学科	分区	影响因子
Q2	ONCOLOGY	Q2	5.036

Cancer Research And Treatment期刊近7年影响因子变化趋势

Cancer Research And Treatment期刊的CiteScore值(CiteScore2021-2022年CiteScore值)

CiteScore	SJR	SNIP	学科类别	分区	排名	百分位
8.70	1.359	1.720	大类：Medicine 小类：Oncology	Q1	56 / 360	84%
8.70	1.359	1.720	大类：Medicine 小类：Cancer Research	Q2	54 / 210	74%

Cancer Research And Treatment期刊近7年自引率变化趋势

上周TOP10